Subscribe for great stories in your community!
Later this week, the U.S. Food and Drug Administration is expected to make a decision on Madrigal Pharmaceuticals’ experimental NASH treatment, writes John George…
Simon Property Group CEO David Simon reacted to his firm’s release of 3Q2022 earnings with assurance that traditional mall shopping is still quite vital…
Before we send you to this site, please subscribe to our daily newsletter.